VX-787

DRUG2 trials

Sponsors

Vertex Pharmaceuticals Incorporated, Janssen Infectious Diseases BVBA

Conditions

HealthyInfluenza Virus

Phase 1

A Study to Assess the Drug-Drug Interaction Between VX-787 and Oseltamivir

CompletedNCT02262715

Janssen Infectious Diseases BVBAHealthy

Start: 2014-07-31End: 2014-10-31Updated: 2014-11-04

Phase 2

A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza Virus

CompletedNCT01561807

Vertex Pharmaceuticals IncorporatedInfluenza Virus

Start: 2012-03-31Updated: 2016-09-02